# To Assess Safety and Efficacy of Bolus Versus Continuous Infusion of Terlipressin in Acute Variceal Bleeding

> **NCT02695862** · NA · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 110 (actual)

## Conditions studied

- Acute Variceal Bleeding

## Interventions

- **DRUG:** Terlipressin

## Key facts

- **NCT ID:** NCT02695862
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-05
- **Primary completion:** 2017-12-10
- **Final completion:** 2018-01-31
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2019-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02695862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02695862, "To Assess Safety and Efficacy of Bolus Versus Continuous Infusion of Terlipressin in Acute Variceal Bleeding". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02695862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*